indican has been researched along with Hyperuricemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Douguchi, S; Hosoya, M; Katoh, M; Ofuchi, K; Osonoi, T; Saito, M | 1 |
| Hsu, CC; Hsu, WL; Huang, PH; Li, SY; Lin, SJ; Lin, YP; Liu, JS; Tarng, DC | 1 |
2 other study(ies) available for indican and Hyperuricemia
| Article | Year |
|---|---|
Efficacy and safety of switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, in hyperuricemic patients with type 2 diabetic kidney disease: Protocol for a single-arm, open-label, prospective, exploratory study.
Topics: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Substitution; Febuxostat; Humans; Hyperuricemia; Indican; Prospective Studies; Uric Acid; Uricosuric Agents | 2022 |
High Uric Acid Ameliorates Indoxyl Sulfate-Induced Endothelial Dysfunction and Is Associated with Lower Mortality among Hemodialysis Patients.
Topics: Adult; Aged; Biomarkers; Cause of Death; Cells, Cultured; Chi-Square Distribution; Endothelial Cells; Female; Humans; Hyperuricemia; Indican; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Nitric Oxide; Oxidative Stress; Prevalence; Prognosis; Proportional Hazards Models; Registries; Risk Factors; Taiwan; Time Factors; Up-Regulation; Uric Acid | 2017 |